99-33760. Agency Information Collection Activities; Announcement of OMB Approval; Guidance for Industry: Changes to an Approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA)  

  • [Federal Register Volume 64, Number 249 (Wednesday, December 29, 1999)]
    [Notices]
    [Pages 73055-73056]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-33760]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    [Docket No. 99D-0529]
    
    
    Agency Information Collection Activities; Announcement of OMB 
    Approval; Guidance for Industry: Changes to an Approved New Drug 
    Application (NDA) or Abbreviated New Drug Application (ANDA)
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
    collection of information entitled ``Guidance for Industry: Changes to 
    an ``Approved NDA or ANDA'' has been approved by the Office of 
    Management and Budget (OMB) under the Paperwork Reduction Act of 1995 
    (the PRA).
    
    FOR FURTHER INFORMATION CONTACT: Denver Presley, Office of Information 
    Resources Management (HFA-250), Food and Drug Administration, 5600 
    Fishers Lane, Rockville, MD 20857, 301-827-1472.
    
    SUPPLEMENTARY INFORMATION: In the Federal Register of November 23, 1999 
    (64 FR 65716), the agency announced that the proposed information 
    collection had been submitted to OMB for review
    
    [[Page 73056]]
    
    and clearance under the emergency processing provisions of the PRA (44 
    U.S.C. 3507(j) and 5 CFR 1320.13). An agency may not conduct or 
    sponsor, and a person is not required to respond to, a collection of 
    information unless it displays a currently valid OMB control number. 
    OMB has now approved the collection of information and has assigned OMB 
    control number 0910-0431. The approval expires on May 31, 2000. A copy 
    of the supporting statement for this information collection is 
    available on the Internet at http://www.fda.gov/ohrms/dockets.
    
        Dated: December 22, 1999.
    William K. Hubbard,
    Senior Associate Commissioner for Policy, Planning, and Legislation.
    [FR Doc. 99-33760 Filed 12-28-99; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
12/29/1999
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
99-33760
Pages:
73055-73056 (2 pages)
Docket Numbers:
Docket No. 99D-0529
PDF File:
99-33760.pdf